comparemela.com
  1. Home
  2. Live Updates
  3. InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 : comparemela.com

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Munich ,Bayern ,Germany ,United States ,Regina Lutz ,Renfeng Guo ,Nielsc Riedemann ,Laurie Doyle ,Katja Arnold ,Drug Administration ,European Medicines Agency ,Mc Services ,Inflarx Pharmaceuticals Inc ,Exchange Commission ,Single Ascending Dose ,Phasei Study ,Chief Scientific Officer ,Chief Executive Officer ,Inflarx Pharmaceuticals ,Ann Arbor ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.